0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Meningococcal Vaccine Market Insights and Forecast to 2027
Published Date: June 2021
|
Report Code: QYRE-Auto-11140
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Global Meningococcal Vaccine Market Insights and Forecast to 2027

Global Meningococcal Vaccine Market Insights and Forecast to 2027

Code: QYRE-Auto-11140
Report
June 2021
118 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Meningococcal Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Meningococcal Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type

Quadrivalent
Bivalent
Others

Segment by Application

Pneumonia
Meningitis
Bacteremia
Others (Arthritis, Conjunctivitis, Urethritis)

BY COMPANY

Novartis
GSK
Merck
CSL
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
China National Biotec Group
Hualan Bio
Walvax
Zhifei

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
1 Study Coverage
1.1 Meningococcal Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Meningococcal Vaccine Market Size Growth Rate by Type
1.4.2 Quadrivalent
1.4.3 Bivalent
1.2.4 Others
1.3 Market by Application
1.3.1 Global Meningococcal Vaccine Market Size Growth Rate by Application
1.3.2 Pneumonia
1.3.3 Meningitis
1.3.4 Bacteremia
1.3.5 Others (Arthritis, Conjunctivitis, Urethritis)
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Meningococcal Vaccine Sales Estimates and Forecasts 2016-2027
2.2 Global Meningococcal Vaccine Revenue Estimates and Forecasts 2016-2027
2.3 Global Meningococcal Vaccine Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Meningococcal Vaccine Regions by Sales
2.4.1 Global Top Meningococcal Vaccine Regions by Sales (2016-2021)
2.4.2 Global Top Meningococcal Vaccine Regions by Sales (2022-2027)
2.5 Global Top Meningococcal Vaccine Regions by Revenue
2.5.1 Global Top Meningococcal Vaccine Regions by Revenue (2016-2021)
2.5.2 Global Top Meningococcal Vaccine Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Meningococcal Vaccine Sales by Manufacturers
3.1.1 Global Top Meningococcal Vaccine Manufacturers by Sales (2016-2021)
3.1.2 Global Top Meningococcal Vaccine Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Meningococcal Vaccine Sales in 2020
3.2 Global Meningococcal Vaccine Revenue by Manufacturers
3.2.1 Global Top Meningococcal Vaccine Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Meningococcal Vaccine Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Meningococcal Vaccine Revenue in 2020
3.3 Global Meningococcal Vaccine Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Meningococcal Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Meningococcal Vaccine Sales by Type
4.1.1 Global Meningococcal Vaccine Historical Sales by Type (2016-2021)
4.1.2 Global Meningococcal Vaccine Forecasted Sales by Type (2022-2027)
4.1.3 Global Meningococcal Vaccine Sales Market Share by Type (2016-2027)
4.2 Global Meningococcal Vaccine Revenue by Type
4.2.1 Global Meningococcal Vaccine Historical Revenue by Type (2016-2021)
4.2.2 Global Meningococcal Vaccine Forecasted Revenue by Type (2022-2027)
4.2.3 Global Meningococcal Vaccine Revenue Market Share by Type (2016-2027)
4.3 Global Meningococcal Vaccine Price by Type
4.3.1 Global Meningococcal Vaccine Price by Type (2016-2021)
4.3.2 Global Meningococcal Vaccine Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Meningococcal Vaccine Sales by Application
5.1.1 Global Meningococcal Vaccine Historical Sales by Application (2016-2021)
5.1.2 Global Meningococcal Vaccine Forecasted Sales by Application (2022-2027)
5.1.3 Global Meningococcal Vaccine Sales Market Share by Application (2016-2027)
5.2 Global Meningococcal Vaccine Revenue by Application
5.2.1 Global Meningococcal Vaccine Historical Revenue by Application (2016-2021)
5.2.2 Global Meningococcal Vaccine Forecasted Revenue by Application (2022-2027)
5.2.3 Global Meningococcal Vaccine Revenue Market Share by Application (2016-2027)
5.3 Global Meningococcal Vaccine Price by Application
5.3.1 Global Meningococcal Vaccine Price by Application (2016-2021)
5.3.2 Global Meningococcal Vaccine Price Forecast by Application (2022-2027)
6 North America
6.1 North America Meningococcal Vaccine Market Size by Type
6.1.1 North America Meningococcal Vaccine Sales by Type (2016-2027)
6.1.2 North America Meningococcal Vaccine Revenue by Type (2016-2027)
6.2 North America Meningococcal Vaccine Market Size by Application
6.2.1 North America Meningococcal Vaccine Sales by Application (2016-2027)
6.2.2 North America Meningococcal Vaccine Revenue by Application (2016-2027)
6.3 North America Meningococcal Vaccine Market Size by Country
6.3.1 North America Meningococcal Vaccine Sales by Country (2016-2027)
6.3.2 North America Meningococcal Vaccine Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Meningococcal Vaccine Market Size by Type
7.1.1 Europe Meningococcal Vaccine Sales by Type (2017-2027)
7.1.2 Europe Meningococcal Vaccine Revenue by Type (2017-2027)
7.2 Europe Meningococcal Vaccine Market Size by Application
7.2.1 Europe Meningococcal Vaccine Sales by Application (2017-2027)
7.2.2 Europe Meningococcal Vaccine Revenue by Application (2017-2027)
7.3 Europe Meningococcal Vaccine Market Size by Country
7.3.1 Europe Meningococcal Vaccine Sales by Country (2017-2027)
7.3.2 Europe Meningococcal Vaccine Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Meningococcal Vaccine Market Size by Type
8.1.1 Asia Pacific Meningococcal Vaccine Sales by Type (2018-2027)
8.1.2 Asia Pacific Meningococcal Vaccine Revenue by Type (2018-2027)
8.2 Asia Pacific Meningococcal Vaccine Market Size by Application
8.2.1 Asia Pacific Meningococcal Vaccine Sales by Application (2018-2027)
8.2.2 Asia Pacific Meningococcal Vaccine Revenue by Application (2018-2027)
8.3 Asia Pacific Meningococcal Vaccine Market Size by Region
8.3.1 Asia Pacific Meningococcal Vaccine Sales by Region (2018-2027)
8.3.2 Asia Pacific Meningococcal Vaccine Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Meningococcal Vaccine Market Size by Type
9.1.1 Latin America Meningococcal Vaccine Sales by Type (2019-2027)
9.1.2 Latin America Meningococcal Vaccine Revenue by Type (2019-2027)
9.2 Latin America Meningococcal Vaccine Market Size by Application
9.2.1 Latin America Meningococcal Vaccine Sales by Application (2019-2027)
9.2.2 Latin America Meningococcal Vaccine Revenue by Application (2019-2027)
9.3 Latin America Meningococcal Vaccine Market Size by Country
9.3.1 Latin America Meningococcal Vaccine Sales by Country (2019-2027)
9.3.2 Latin America Meningococcal Vaccine Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Meningococcal Vaccine Market Size by Type
6.1.1 Middle East and Africa Meningococcal Vaccine Sales by Type (2016-2027)
6.1.2 Middle East and Africa Meningococcal Vaccine Revenue by Type (2016-2027)
6.2 Middle East and Africa Meningococcal Vaccine Market Size by Application
6.2.1 Middle East and Africa Meningococcal Vaccine Sales by Application (2016-2027)
6.2.2 Middle East and Africa Meningococcal Vaccine Revenue by Application (2016-2027)
6.3 Middle East and Africa Meningococcal Vaccine Market Size by Country
6.3.1 Middle East and Africa Meningococcal Vaccine Sales by Country (2016-2027)
6.3.2 Middle East and Africa Meningococcal Vaccine Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Overview
11.1.3 Novartis Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Novartis Meningococcal Vaccine Product Description
11.1.5 Novartis Related Developments
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Overview
11.2.3 GSK Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 GSK Meningococcal Vaccine Product Description
11.2.5 GSK Related Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Overview
11.3.3 Merck Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Merck Meningococcal Vaccine Product Description
11.3.5 Merck Related Developments
11.4 CSL
11.4.1 CSL Corporation Information
11.4.2 CSL Overview
11.4.3 CSL Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 CSL Meningococcal Vaccine Product Description
11.4.5 CSL Related Developments
11.5 Baxter
11.5.1 Baxter Corporation Information
11.5.2 Baxter Overview
11.5.3 Baxter Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Baxter Meningococcal Vaccine Product Description
11.5.5 Baxter Related Developments
11.6 JN International Medical Corporation
11.6.1 JN International Medical Corporation Corporation Information
11.6.2 JN International Medical Corporation Overview
11.6.3 JN International Medical Corporation Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 JN International Medical Corporation Meningococcal Vaccine Product Description
11.6.5 JN International Medical Corporation Related Developments
11.7 Serum Institute of India
11.7.1 Serum Institute of India Corporation Information
11.7.2 Serum Institute of India Overview
11.7.3 Serum Institute of India Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Serum Institute of India Meningococcal Vaccine Product Description
11.7.5 Serum Institute of India Related Developments
11.8 Bio-Med
11.8.1 Bio-Med Corporation Information
11.8.2 Bio-Med Overview
11.8.3 Bio-Med Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Bio-Med Meningococcal Vaccine Product Description
11.8.5 Bio-Med Related Developments
11.9 China National Biotec Group
11.9.1 China National Biotec Group Corporation Information
11.9.2 China National Biotec Group Overview
11.9.3 China National Biotec Group Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 China National Biotec Group Meningococcal Vaccine Product Description
11.9.5 China National Biotec Group Related Developments
11.10 Hualan Bio
11.10.1 Hualan Bio Corporation Information
11.10.2 Hualan Bio Overview
11.10.3 Hualan Bio Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Hualan Bio Meningococcal Vaccine Product Description
11.10.5 Hualan Bio Related Developments
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Overview
11.1.3 Novartis Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Novartis Meningococcal Vaccine Product Description
11.1.5 Novartis Related Developments
11.12 Zhifei
11.12.1 Zhifei Corporation Information
11.12.2 Zhifei Overview
11.12.3 Zhifei Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 Zhifei Product Description
11.12.5 Zhifei Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Meningococcal Vaccine Value Chain Analysis
12.2 Meningococcal Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Meningococcal Vaccine Production Mode & Process
12.4 Meningococcal Vaccine Sales and Marketing
12.4.1 Meningococcal Vaccine Sales Channels
12.4.2 Meningococcal Vaccine Distributors
12.5 Meningococcal Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Meningococcal Vaccine Industry Trends
13.2 Meningococcal Vaccine Market Drivers
13.3 Meningococcal Vaccine Market Challenges
13.4 Meningococcal Vaccine Market Restraints
14 Key Findings in The Global Meningococcal Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Meningococcal Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of Quadrivalent
    Table 3. Major Manufacturers of Bivalent
    Table 4. Major Manufacturers of Others
    Table 5. Global Meningococcal Vaccine Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
    Table 6. Global Meningococcal Vaccine Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
    Table 7. Global Meningococcal Vaccine Sales by Region (2016-2021) & (K Dose)
    Table 8. Global Meningococcal Vaccine Sales Market Share by Region (2016-2021)
    Table 9. Global Meningococcal Vaccine Sales by Region (2016-2021) & (K Dose)
    Table 10. Global Meningococcal Vaccine Sales Market Share by Region (2022-2027)
    Table 11. Global Meningococcal Vaccine Revenue by Region (2016-2021) & (US$ Million)
    Table 12. Global Meningococcal Vaccine Revenue Market Share by Region (2016-2021)
    Table 13. Global Meningococcal Vaccine Revenue by Region (2022-2027) & (US$ Million)
    Table 14. Global Meningococcal Vaccine Revenue Market Share by Region (2022-2027)
    Table 15. Global Meningococcal Vaccine Sales by Manufacturers (2016-2021) & (K Dose)
    Table 16. Global Meningococcal Vaccine Sales Share by Manufacturers (2016-2021)
    Table 17. Global Meningococcal Vaccine Revenue by Manufacturers (2016-2021) & (US$ Million)
    Table 18. Global Meningococcal Vaccine Revenue Share by Manufacturers (2016-2021)
    Table 19. Meningococcal Vaccine Price by Manufacturers 2016-2021 (USD/Dose)
    Table 20. Global Meningococcal Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Meningococcal Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Vaccine as of 2020)
    Table 22. Meningococcal Vaccine Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Meningococcal Vaccine Product Offered
    Table 24. Date of Manufacturers Enter into Meningococcal Vaccine Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Meningococcal Vaccine Sales by Type (2016-2021) & (K Dose)
    Table 27. Global Meningococcal Vaccine Sales by Type (2022-2027) & (K Dose)
    Table 28. Global Meningococcal Vaccine Sales Share by Type (2016-2021)
    Table 29. Global Meningococcal Vaccine Sales Share by Type (2022-2027)
    Table 30. Global Meningococcal Vaccine Revenue by Type (2016-2021) & (US$ Million)
    Table 31. Global Meningococcal Vaccine Revenue by Type (2022-2027) & (US$ Million)
    Table 32. Global Meningococcal Vaccine Revenue Share by Type (2016-2021)
    Table 33. Global Meningococcal Vaccine Revenue Share by Type (2022-2027)
    Table 34. Meningococcal Vaccine Price by Type (2016-2021) & (USD/Dose)
    Table 35. Global Meningococcal Vaccine Price Forecast by Type (2022-2027) & (USD/Dose)
    Table 36. Global Meningococcal Vaccine Sales by Application (2016-2021) & (K Dose)
    Table 37. Global Meningococcal Vaccine Sales by Application (2022-2027) & (K Dose)
    Table 38. Global Meningococcal Vaccine Sales Share by Application (2016-2021)
    Table 39. Global Meningococcal Vaccine Sales Share by Application (2022-2027)
    Table 40. Global Meningococcal Vaccine Revenue by Application (2016-2021) & (US$ Million)
    Table 41. Global Meningococcal Vaccine Revenue by Application (2022-2027) & (US$ Million)
    Table 42. Global Meningococcal Vaccine Revenue Share by Application (2016-2021)
    Table 43. Global Meningococcal Vaccine Revenue Share by Application (2022-2027)
    Table 44. Meningococcal Vaccine Price by Application (2016-2021) & (USD/Dose)
    Table 45. Global Meningococcal Vaccine Price Forecast by Application (2022-2027) & (USD/Dose)
    Table 46. North America Meningococcal Vaccine Sales by Type (2016-2021) & (K Dose)
    Table 47. North America Meningococcal Vaccine Sales by Type (2022-2027) & (K Dose)
    Table 48. North America Meningococcal Vaccine Revenue by Type (2016-2021) & (US$ Million)
    Table 49. North America Meningococcal Vaccine Revenue by Type (2022-2027) & (US$ Million)
    Table 50. North America Meningococcal Vaccine Sales by Application (2016-2021) & (K Dose)
    Table 51. North America Meningococcal Vaccine Sales by Application (2022-2027) & (K Dose)
    Table 52. North America Meningococcal Vaccine Revenue by Application (2016-2021) & (US$ Million)
    Table 53. North America Meningococcal Vaccine Revenue by Application (2022-2027) & (US$ Million)
    Table 54. North America Meningococcal Vaccine Sales by Country (2016-2021) & (K Dose)
    Table 55. North America Meningococcal Vaccine Sales by Country (2022-2027) & (K Dose)
    Table 56. North America Meningococcal Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 57. North America Meningococcal Vaccine Revenue by Country (2022-2027) & (US$ Million)
    Table 58. Europe Meningococcal Vaccine Sales by Type (2016-2021) & (K Dose)
    Table 59. Europe Meningococcal Vaccine Sales by Type (2022-2027) & (K Dose)
    Table 60. Europe Meningococcal Vaccine Revenue by Type (2016-2021) & (US$ Million)
    Table 61. Europe Meningococcal Vaccine Revenue by Type (2022-2027) & (US$ Million)
    Table 62. Europe Meningococcal Vaccine Sales by Application (2016-2021) & (K Dose)
    Table 63. Europe Meningococcal Vaccine Sales by Application (2022-2027) & (K Dose)
    Table 64. Europe Meningococcal Vaccine Revenue by Application (2016-2021) & (US$ Million)
    Table 65. Europe Meningococcal Vaccine Revenue by Application (2022-2027) & (US$ Million)
    Table 66. Europe Meningococcal Vaccine Sales by Country (2016-2021) & (K Dose)
    Table 67. Europe Meningococcal Vaccine Sales by Country (2022-2027) & (K Dose)
    Table 68. Europe Meningococcal Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 69. Europe Meningococcal Vaccine Revenue by Country (2022-2027) & (US$ Million)
    Table 70. Asia Pacific Meningococcal Vaccine Sales by Type (2016-2021) & (K Dose)
    Table 71. Asia Pacific Meningococcal Vaccine Sales by Type (2022-2027) & (K Dose)
    Table 72. Asia Pacific Meningococcal Vaccine Revenue by Type (2016-2021) & (US$ Million)
    Table 73. Asia Pacific Meningococcal Vaccine Revenue by Type (2022-2027) & (US$ Million)
    Table 74. Asia Pacific Meningococcal Vaccine Sales by Application (2016-2021) & (K Dose)
    Table 75. Asia Pacific Meningococcal Vaccine Sales by Application (2022-2027) & (K Dose)
    Table 76. Asia Pacific Meningococcal Vaccine Revenue by Application (2016-2021) & (US$ Million)
    Table 77. Asia Pacific Meningococcal Vaccine Revenue by Application (2022-2027) & (US$ Million)
    Table 78. Asia Pacific Meningococcal Vaccine Sales by Region (2016-2021) & (K Dose)
    Table 79. Asia Pacific Meningococcal Vaccine Sales by Region (2022-2027) & (K Dose)
    Table 80. Asia Pacific Meningococcal Vaccine Revenue by Region (2016-2021) & (US$ Million)
    Table 81. Asia Pacific Meningococcal Vaccine Revenue by Region (2022-2027) & (US$ Million)
    Table 82. Latin America Meningococcal Vaccine Sales by Type (2016-2021) & (K Dose)
    Table 83. Latin America Meningococcal Vaccine Sales by Type (2022-2027) & (K Dose)
    Table 84. Latin America Meningococcal Vaccine Revenue by Type (2016-2021) & (US$ Million)
    Table 85. Latin America Meningococcal Vaccine Revenue by Type (2022-2027) & (US$ Million)
    Table 86. Latin America Meningococcal Vaccine Sales by Application (2016-2021) & (K Dose)
    Table 87. Latin America Meningococcal Vaccine Sales by Application (2022-2027) & (K Dose)
    Table 88. Latin America Meningococcal Vaccine Revenue by Application (2016-2021) & (US$ Million)
    Table 89. Latin America Meningococcal Vaccine Revenue by Application (2022-2027) & (US$ Million)
    Table 90. Latin America Meningococcal Vaccine Sales by Country (2016-2021) & (K Dose)
    Table 91. Latin America Meningococcal Vaccine Sales by Country (2022-2027) & (K Dose)
    Table 92. Latin America Meningococcal Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 93. Latin America Meningococcal Vaccine Revenue by Country (2022-2027) & (US$ Million)
    Table 94. Middle East and Africa Meningococcal Vaccine Sales by Type (2016-2021) & (K Dose)
    Table 95. Middle East and Africa Meningococcal Vaccine Sales by Type (2022-2027) & (K Dose)
    Table 96. Middle East and Africa Meningococcal Vaccine Revenue by Type (2016-2021) & (US$ Million)
    Table 97. Middle East and Africa Meningococcal Vaccine Revenue by Type (2022-2027) & (US$ Million)
    Table 98. Middle East and Africa Meningococcal Vaccine Sales by Application (2016-2021) & (K Dose)
    Table 99. Middle East and Africa Meningococcal Vaccine Sales by Application (2022-2027) & (K Dose)
    Table 100. Middle East and Africa Meningococcal Vaccine Revenue by Application (2016-2021) & (US$ Million)
    Table 101. Middle East and Africa Meningococcal Vaccine Revenue by Application (2022-2027) & (US$ Million)
    Table 102. Middle East and Africa Meningococcal Vaccine Sales by Country (2016-2021) & (K Dose)
    Table 103. Middle East and Africa Meningococcal Vaccine Sales by Country (2022-2027) & (K Dose)
    Table 104. Middle East and Africa Meningococcal Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 105. Middle East and Africa Meningococcal Vaccine Revenue by Country (2022-2027) & (US$ Million)
    Table 106. Novartis Corporation Information
    Table 107. Novartis Description and Major Businesses
    Table 108. Novartis Meningococcal Vaccine Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 109. Novartis Meningococcal Vaccine Product
    Table 110. Novartis Recent Developments
    Table 111. GSK Corporation Information
    Table 112. GSK Description and Major Businesses
    Table 113. GSK Meningococcal Vaccine Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 114. GSK Meningococcal Vaccine Product
    Table 115. GSK Recent Developments
    Table 116. Merck Corporation Information
    Table 117. Merck Description and Major Businesses
    Table 118. Merck Meningococcal Vaccine Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 119. Merck Meningococcal Vaccine Product
    Table 120. Merck Recent Developments
    Table 121. CSL Corporation Information
    Table 122. CSL Description and Major Businesses
    Table 123. CSL Meningococcal Vaccine Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 124. CSL Meningococcal Vaccine Product
    Table 125. CSL Recent Developments
    Table 126. Baxter Corporation Information
    Table 127. Baxter Description and Major Businesses
    Table 128. Baxter Meningococcal Vaccine Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 129. Baxter Meningococcal Vaccine Product
    Table 130. Baxter Recent Developments
    Table 131. JN International Medical Corporation Corporation Information
    Table 132. JN International Medical Corporation Description and Major Businesses
    Table 133. JN International Medical Corporation Meningococcal Vaccine Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 134. JN International Medical Corporation Meningococcal Vaccine Product
    Table 135. JN International Medical Corporation Recent Developments
    Table 136. Serum Institute of India Corporation Information
    Table 137. Serum Institute of India Description and Major Businesses
    Table 138. Serum Institute of India Meningococcal Vaccine Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 139. Serum Institute of India Meningococcal Vaccine Product
    Table 140. Serum Institute of India Recent Developments
    Table 141. Bio-Med Corporation Information
    Table 142. Bio-Med Description and Major Businesses
    Table 143. Bio-Med Meningococcal Vaccine Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 144. Bio-Med Meningococcal Vaccine Product
    Table 145. Bio-Med Recent Developments
    Table 146. China National Biotec Group Corporation Information
    Table 147. China National Biotec Group Description and Major Businesses
    Table 148. China National Biotec Group Meningococcal Vaccine Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 149. China National Biotec Group Meningococcal Vaccine Product
    Table 150. China National Biotec Group Recent Developments
    Table 151. Hualan Bio Corporation Information
    Table 152. Hualan Bio Description and Major Businesses
    Table 153. Hualan Bio Meningococcal Vaccine Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 154. Hualan Bio Meningococcal Vaccine Product
    Table 155. Hualan Bio Recent Developments
    Table 156. Walvax Corporation Information
    Table 157. Walvax Description and Major Businesses
    Table 158. Walvax Meningococcal Vaccine Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 159. Walvax Meningococcal Vaccine Product
    Table 160. Walvax Recent Developments
    Table 161. Zhifei Corporation Information
    Table 162. Zhifei Description and Major Businesses
    Table 163. Zhifei Meningococcal Vaccine Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 164. Zhifei Meningococcal Vaccine Product
    Table 165. Zhifei Recent Developments
    Table 166. Key Raw Materials Lists
    Table 167. Raw Materials Key Suppliers Lists
    Table 168. Meningococcal Vaccine Distributors List
    Table 169. Meningococcal Vaccine Customers List
    Table 170. Meningococcal Vaccine Market Trends
    Table 171. Meningococcal Vaccine Market Drivers
    Table 172. Meningococcal Vaccine Market Challenges
    Table 173. Meningococcal Vaccine Market Restraints
    Table 174. Research Programs/Design for This Report
    Table 175. Key Data Information from Secondary Sources
    Table 176. Key Data Information from Primary Sources
List of Figures
    Figure 1. Meningococcal Vaccine Product Picture
    Figure 2. Global Meningococcal Vaccine Market Share by Type in 2020 & 2027
    Figure 3. Quadrivalent Product Picture
    Figure 4. Bivalent Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Meningococcal Vaccine Sales Market Share by Application in 2020 & 2027
    Figure 7. Pneumonia
    Figure 8. Meningitis
    Figure 9. Bacteremia
    Figure 10. Others (Arthritis, Conjunctivitis, Urethritis)
    Figure 11. Meningococcal Vaccine Report Years Considered
    Figure 12. Global Meningococcal Vaccine Sales 2016-2027 (K Dose)
    Figure 13. Global Meningococcal Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global Meningococcal Vaccine Revenue 2016-2027 (US$ Million)
    Figure 15. Global Meningococcal Vaccine Revenue Market Share by Region in Percentage: 2020 Versus 2027
    Figure 16. Global Meningococcal Vaccine Sales Market Share by Region (2016-2021)
    Figure 17. Global Meningococcal Vaccine Sales Market Share by Region (2022-2027)
    Figure 18. North America Meningococcal Vaccine Sales YoY (2016-2027) & (K Dose)
    Figure 19. North America Meningococcal Vaccine Revenue YoY (2016-2027) & (US$ Million)
    Figure 20. Europe Meningococcal Vaccine Sales YoY (2016-2027) & (K Dose)
    Figure 21. Europe Meningococcal Vaccine Revenue YoY (2016-2027) & (US$ Million)
    Figure 22. Asia-Pacific Meningococcal Vaccine Sales YoY (2016-2027) & (K Dose)
    Figure 23. Asia-Pacific Meningococcal Vaccine Revenue YoY (2016-2027) & (US$ Million)
    Figure 24. Latin America Meningococcal Vaccine Sales YoY (2016-2027) & (K Dose)
    Figure 25. Latin America Meningococcal Vaccine Revenue YoY (2016-2027) & (US$ Million)
    Figure 26. Middle East & Africa Meningococcal Vaccine Sales YoY (2016-2027) & (K Dose)
    Figure 27. Middle East & Africa Meningococcal Vaccine Revenue YoY (2016-2027) & (US$ Million)
    Figure 28. The Top 10 and Top 5 Players Market Share by Meningococcal Vaccine Sales in 2020
    Figure 29. The Top 10 and Top 5 Players Market Share by Meningococcal Vaccine Revenue in 2020
    Figure 30. Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
    Figure 31. Global Meningococcal Vaccine Sales Market Share by Type (2016-2027)
    Figure 32. Global Meningococcal Vaccine Revenue Market Share by Type (2016-2027)
    Figure 33. Global Meningococcal Vaccine Sales Market Share by Application (2016-2027)
    Figure 34. Global Meningococcal Vaccine Revenue Market Share by Application (2016-2027)
    Figure 35. North America Meningococcal Vaccine Sales Market Share by Type (2016-2027)
    Figure 36. North America Meningococcal Vaccine Revenue Market Share by Type (2016-2027)
    Figure 37. North America Meningococcal Vaccine Sales Market Share by Application (2016-2027)
    Figure 38. North America Meningococcal Vaccine Revenue Market Share by Application (2016-2027)
    Figure 39. North America Meningococcal Vaccine Sales Share by Country (2016-2027)
    Figure 40. North America Meningococcal Vaccine Revenue Share by Country (2016-2027)
    Figure 41. U.S. Meningococcal Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 42. Canada Meningococcal Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 43. Europe Meningococcal Vaccine Sales Market Share by Type (2016-2027)
    Figure 44. Europe Meningococcal Vaccine Revenue Market Share by Type (2016-2027)
    Figure 45. Europe Meningococcal Vaccine Sales Market Share by Application (2016-2027)
    Figure 46. Europe Meningococcal Vaccine Revenue Market Share by Application (2016-2027)
    Figure 47. Europe Meningococcal Vaccine Sales Share by Country (2016-2027)
    Figure 48. Europe Meningococcal Vaccine Revenue Share by Country (2016-2027)
    Figure 49. Germany Meningococcal Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 50. France Meningococcal Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 51. U.K. Meningococcal Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 52. Italy Meningococcal Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 53. Russia Meningococcal Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 54. Asia Pacific Meningococcal Vaccine Sales Market Share by Type (2016-2027)
    Figure 55. Asia Pacific Meningococcal Vaccine Revenue Market Share by Type (2016-2027)
    Figure 56. Asia Pacific Meningococcal Vaccine Sales Market Share by Application (2016-2027)
    Figure 57. Asia Pacific Meningococcal Vaccine Revenue Market Share by Application (2016-2027)
    Figure 58. Asia Pacific Meningococcal Vaccine Sales Share by Region (2016-2027)
    Figure 59. Asia Pacific Meningococcal Vaccine Revenue Share by Region (2016-2027)
    Figure 60. China Meningococcal Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 61. Japan Meningococcal Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 62. South Korea Meningococcal Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 63. India Meningococcal Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 64. Australia Meningococcal Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 65. Taiwan Meningococcal Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 66. Indonesia Meningococcal Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 67. Thailand Meningococcal Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 68. Malaysia Meningococcal Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 69. Philippines Meningococcal Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 70. Latin America Meningococcal Vaccine Sales Market Share by Type (2016-2027)
    Figure 71. Latin America Meningococcal Vaccine Revenue Market Share by Type (2016-2027)
    Figure 72. Latin America Meningococcal Vaccine Sales Market Share by Application (2016-2027)
    Figure 73. Latin America Meningococcal Vaccine Revenue Market Share by Application (2016-2027)
    Figure 74. Latin America Meningococcal Vaccine Sales Share by Country (2016-2027)
    Figure 75. Latin America Meningococcal Vaccine Revenue Share by Country (2016-2027)
    Figure 76. Mexico Meningococcal Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 77. Brazil Meningococcal Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 78. Argentina Meningococcal Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 79. Middle East and Africa Meningococcal Vaccine Sales Market Share by Type (2016-2027)
    Figure 80. Middle East and Africa Meningococcal Vaccine Revenue Market Share by Type (2016-2027)
    Figure 81. Middle East and Africa Meningococcal Vaccine Sales Market Share by Application (2016-2027)
    Figure 82. Middle East and Africa Meningococcal Vaccine Revenue Market Share by Application (2016-2027)
    Figure 83. Middle East and Africa Meningococcal Vaccine Sales Share by Country (2016-2027)
    Figure 84. Middle East and Africa Meningococcal Vaccine Revenue Share by Country (2016-2027)
    Figure 85. Turkey Meningococcal Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 86. Saudi Arabia Meningococcal Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 87. U.A.E Meningococcal Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 88. Meningococcal Vaccine Value Chain
    Figure 89. Meningococcal Vaccine Production Process
    Figure 90. Channels of Distribution
    Figure 91. Distributors Profiles
    Figure 92. Bottom-up and Top-down Approaches for This Report
    Figure 93. Data Triangulation
    Figure 94. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Bioinformatics Barcelona

RELATED REPORTS

Global Infectious Disease Diagnosis Market Size Status and Forecast 2021 2027
Global Infectious Disease Diagnosis Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-10N1843
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global Infectious Disease Diagnostics Testing Market Size Status and Forecast 2021 2027
Global Infectious Disease Diagnostics Testing Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Othe-2O272
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global HPV Associated Disorder Market Size Status and Forecast 2021 2027
Global HPV Associated Disorder Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-28G2646
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global Hepatitis B Treatment Market Size Status and Forecast 2021 2027
Global Hepatitis B Treatment Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-34S2647
Sun Jul 18 00:00:00 UTC 2021

Add to Cart